Mi F S
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing.
Zhonghua Zhong Liu Za Zhi. 1993 Mar;15(2):94-6.
The synergetic radiosensitizing effect of isomers S-8932 and S-8933 on HeLa-S3 cell-line was investigated in vitro using cell colony forming assay. The results suggested that the combined use of the two isomers showed a lower cytotoxicity than their single use. The ID50 was 55.3 mM. Their synergetic radiosensitizing effect on HeLa-S3 cells under hypoxic condition was higher than either one used alone. The SER of the combined one at 4mM was 1.98 (D0 ratio) and 1.79 (D9 ratio) indicating a sensitizing effect at both low and high radiation doses. The type of the synergetic radiosensitization of the two compounds indicates that they are radiosensitizers of "alpha-beta" type according to the analysis of their molecular models. If the two isomers are used in combination in fractionation radiotherapy, less number of fraction and larger dose per fraction should be selected in the scheme of treatment.
采用细胞集落形成试验在体外研究了异构体S - 8932和S - 8933对HeLa - S3细胞系的协同放射增敏作用。结果表明,两种异构体联合使用时的细胞毒性低于单独使用时。半数抑制浓度(ID50)为55.3 mM。它们在缺氧条件下对HeLa - S3细胞的协同放射增敏作用高于单独使用任何一种异构体。联合使用时在4 mM时的增敏增强比(SER)为1.98(D0比值)和1.79(D9比值),表明在低剂量和高剂量辐射下均有增敏作用。根据两种化合物分子模型的分析,其协同放射增敏的类型表明它们是“α-β”型放射增敏剂。如果在分割放射治疗中联合使用这两种异构体,则在治疗方案中应选择较少的分割次数和较大的每次分割剂量。